Spots Global Cancer Trial Database for prostatic adenocarcinoma

Every month we try and update this database with for prostatic adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Dose Escalation Using Fiducial Markers in Image Guided Volumetric Modulated Arc Therapy to the Focal Lesion Micro Boost of Localized Prostate Cancer	NCT03384199	Prostatic Adeno...	Dose escalation...	40 Years - 80 Years	Kasr El Aini Hospital
Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma	NCT02876991	Bone Metastasis	Sodium fluoride...	18 Years -	Central Hospital, Nancy, France
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With BRCA1/2 Gene Alterations	NCT05498272	Prostate Cancer BRCA1 Mutation BRCA2 Mutation Prostatic Adeno... High-Risk Cance...	Olaparib LHRH agonist	18 Years -	Hoosier Cancer Research Network
Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid	NCT02361515	Prostatic Adeno...	Moderate hypofr... Stereotactic ra...	18 Years - 80 Years	Hospices Civils de Lyon
Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI	NCT04063800	Prostatic Adeno...		18 Years -	University Hospital, Brest
Dose Escalation Using Fiducial Markers in Image Guided Volumetric Modulated Arc Therapy to the Focal Lesion Micro Boost of Localized Prostate Cancer	NCT03384199	Prostatic Adeno...	Dose escalation...	40 Years - 80 Years	Kasr El Aini Hospital
An Open Label Phase II Study of First-Line Maintenance Enzalutamide Following Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Castration-Naive Prostatic Adenocarcinoma	NCT06015321	Prostatic Adeno...	Enzalutamide	20 Years -	Samsung Medical Center
Sipuleucel-T Manufacturing Demonstration Study	NCT01477749	Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance...	sipuleucel-T	18 Years -	Dendreon
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer	NCT01431391	Prostatic Neopl... Prostate Cancer Prostatic Adeno...	sipuleucel-T leuprolide acet...	18 Years -	Dendreon
Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer	NCT01542021	Prostate Cancer Prostatic Adeno...	degarelix injec... degarelix injec... androgen depriv...	18 Years -	Memorial Sloan Kettering Cancer Center
Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy	NCT00065442	Prostate Cancer	Sipuleucel-T APC-Placebo	18 Years -	Dendreon
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen	NCT00715078	Prostate Cancer	sipuleucel-T	18 Years -	Dendreon
Sipuleucel-T Manufacturing Demonstration Study	NCT01477749	Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance...	sipuleucel-T	18 Years -	Dendreon
Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer	NCT00901342	Prostate Cancer	sipuleucel-T	18 Years -	Dendreon

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: